|
by Stephanie Neil, MA Editorial Staff Posted on Friday, June 20, 2008 10:04:22 AM   | Abstract: | Web-based MES includes new recipe capabilities and tracking technology to improve communications and response time during clinical trials. |
Honeywell announced an upgraded version of its POMSnet Web-based manufacturing execution system (MES) for the pharmaceutical industry that includes new recipe capabilities and a tracking technology to reduce patient risk by improving communication and response time during clinical trials.
POMSnet helps improve pharmaceutical manufacturing performance by controlling and tracking all aspects of production, promoting best practices, and capturing critical data for compliance, quality control, and process improvement. The POMSnet upgrade supports multiple languages and offers improved material handling and new recipe features that can reduce cycle times, rollout time for new procedures, production errors, and compliance costs. A new batch rescaling tool automatically adjusts recipes to partial batch quantities and includes new weighing methods and dispensing rules for increased accuracy. The system can reduce production errors up to 50%, the company said.
The tracking tool, POMStrace, reduces the effort to maintain and track inventory records for supplies used in clinical trials. The system provides up-to-date information on supply levels, including patient distribution. It also can reduce potential risks to patients in case of a cancelled or recalled trial by blocking dispensing and providing immediate access to all logistical information. The system produces a traceability record of each patient kit and provides accounting for all materials.
[Click to continue] |